Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
The Journal of Comparative Neurology
|
September 24, 2004
Variable effects of chronic subcutaneous administration of rotenone on striatal histology
Chunni Zhu, Patrick Vourc'h, Pierre-Olivier Fernagut, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 25, 2005
3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease
Dong-Youn Hwang, Sheila M Fleming, Paul Ardayfio, et al.
Frontiers in Neurology
|
July 27, 2013
Impaired baroreflex function in mice overexpressing alpha-synuclein
Sheila M Fleming, Maria C Jordan, Caitlin K Mulligan, et al.
Pharmacology Research & Perspectives
|
December 16, 2014
Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein
Iddo Magen, Regina Ostritsky, Franziska Richter, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 10, 2020
Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration
Matthew L Neal, Sheila M Fleming, Kevin M Budge, et al.
Molecular and Cellular Neurosciences
|
January 4, 2011
A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions
Sheila M Fleming, Caitlin K Mulligan, Franziska Richter, et al.
International Journal of Molecular Sciences
|
August 14, 2025
Phenotype Differences Between ATP13A2 Heterozygous and Knockout Mice Across Aging
Kristina Croucher, Josephine K Lepp, Jennifer Bechtold, et al.
Journal of Neuroscience Research
|
April 9, 2023
Cognitive dysfunction and increased phosphorylated tau are associated with reduced O-GlcNAc signaling in an aging mouse model of metabolic syndrome
Shreya Gupta, Sanjay K A Jinka, Saugat Khanal, et al.
Plos One
|
December 7, 2013
Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system
Sara E Gombash, Fredric P Manfredsson, Christopher J Kemp, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 21, 2009
Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein
Xiao-Hong Lu, Sheila M Fleming, Bernhard Meurers, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
The Journal of Comparative Neurology
|
September 24, 2004
Variable effects of chronic subcutaneous administration of rotenone on striatal histology
Chunni Zhu, Patrick Vourc'h, Pierre-Olivier Fernagut, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 25, 2005
3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease
Dong-Youn Hwang, Sheila M Fleming, Paul Ardayfio, et al.
Frontiers in Neurology
|
July 27, 2013
Impaired baroreflex function in mice overexpressing alpha-synuclein
Sheila M Fleming, Maria C Jordan, Caitlin K Mulligan, et al.
Pharmacology Research & Perspectives
|
December 16, 2014
Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein
Iddo Magen, Regina Ostritsky, Franziska Richter, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 10, 2020
Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration
Matthew L Neal, Sheila M Fleming, Kevin M Budge, et al.
Molecular and Cellular Neurosciences
|
January 4, 2011
A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions
Sheila M Fleming, Caitlin K Mulligan, Franziska Richter, et al.
International Journal of Molecular Sciences
|
August 14, 2025
Phenotype Differences Between ATP13A2 Heterozygous and Knockout Mice Across Aging
Kristina Croucher, Josephine K Lepp, Jennifer Bechtold, et al.
Journal of Neuroscience Research
|
April 9, 2023
Cognitive dysfunction and increased phosphorylated tau are associated with reduced O-GlcNAc signaling in an aging mouse model of metabolic syndrome
Shreya Gupta, Sanjay K A Jinka, Saugat Khanal, et al.
Plos One
|
December 7, 2013
Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system
Sara E Gombash, Fredric P Manfredsson, Christopher J Kemp, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 21, 2009
Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein
Xiao-Hong Lu, Sheila M Fleming, Bernhard Meurers, et al.
Page
of 6